Full Description
This fourth volume in an exciting and detailed series on contact allergens and drug allergy provides monographs of all 507 systemic drugs which have caused delayed-type cutaneous drug hypersensitivity reactions and/or occupational allergic contact dermatitis. The monographs present: Identification section; Occupational allergic contact dermatitis; and Cutaneous adverse drug reactions from systemic drugs caused by type IV (delayed-type) hypersensitivity, as shown by positive patch tests (e.g. maculopapular eruption, acute generalized exanthematous pustulosis [AGEP], symmetrical drug-related intertriginous and flexural exanthema [SDRIFE], fixed drug eruption, drug reaction with eosinophilia and systemic symptoms [DRESS], and photosensitivity). Separate chapters present an overview of the spectrum of allergic cutaneous drug reactions, diagnostic tests, immediate contact reactions (contact urticaria), and systemic drugs that have acquired delayed-type hypersensitivity only by cross-reactivity.
Key Features:
Presents monographs of all known systemic drugs which have caused delayed allergic cutaneous drug reactions and/or occupational allergic contact dermatitis
Provides an extensive literature review of relevant topics of allergenic systemic drugs, part of which is hard or impossible to find in database searches
Identifies IUPAC names, synonyms, CAS and EC numbers, structural and chemical formulas, Merck Index monographs, and advises on patch testing
Presents immediate contact reactions (contact urticaria) from systemics drugs and delayed-type hypersensitivity in drugs caused only by cross-reactivity
Covers an extensive amount of information to benefit dermatologists, allergists, and all others interested in drug allergy
Contents
Introduction. The spectrum of cutaneous adverse drug reactions from systemic drugs caused by delayedtype hypersensitivity. Monographs of systemic drugs that have caused cutaneous adverse drug reactions from delayed-type hypersensitivity. Diagnostic tests in suspected cutaneous adverse drug reactions from systemic drugs. Immediate contact reactions (contact urticaria) from systemic drugs. Systemic drugs that have acquired delayed-type hypersensitivity only by cross-reactivity.
